ARTICLE SUMMARY:
After years that saw investors fleeing medical devices, a host of new funds and new entrants are breathing life into medtech start-ups. A case in point: Vensana Capital, a $225 million fund recently launched by industry veterans Kirk Nielsen and Justin Klein.
Just a few years ago, the question, “Why would anyone want to start anew fund in medtech?” would have been deemed rhetorical, with a clear implication that no one would.Indeed, not only were few VCs coming new into the space, many established medtech investors were scaling back or leaving altogether.
